Supplementary Figure S1 from First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer
Year: 2023
Type: supplementary-materials
Abstract: Survival curves for RX-5902 treatment and Abraxane and Vehicle control in vivo
Authors: Anna Capasso, Stacey M. Bagby, Kyrie L. Dailey, Naomi Currimjee, Betelehem W. Yacob, Anastasia Ionkina, Julie G. Frank, Deog Joong Kim, Christina George, Young B. Lee, Ely Benaim, Brian Gittleman, Sarah J. Hartman, Aik Choon Tan, Jihye Kim, Todd M. Pitts, S. Gail Eckhardt, John J. Tentler, Jennifer R. Diamond
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362548249